$4.27 Billion in Sales Expected for Molina Healthcare, Inc. (NYSE:MOH) This Quarter

Wall Street analysts predict that Molina Healthcare, Inc. (NYSE:MOH) will post $4.27 billion in sales for the current quarter, Zacks reports. Five analysts have issued estimates for Molina Healthcare’s earnings. The lowest sales estimate is $4.25 billion and the highest is $4.30 billion. Molina Healthcare posted sales of $4.66 billion during the same quarter last year, which suggests a negative year over year growth rate of 8.4%. The company is scheduled to announce its next quarterly earnings results on Monday, February 10th.

On average, analysts expect that Molina Healthcare will report full year sales of $16.80 billion for the current year, with estimates ranging from $16.69 billion to $16.86 billion. For the next financial year, analysts expect that the business will post sales of $17.91 billion, with estimates ranging from $17.43 billion to $18.39 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover Molina Healthcare.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $2.80 EPS for the quarter, beating the Zacks’ consensus estimate of $2.70 by $0.10. Molina Healthcare had a net margin of 4.47% and a return on equity of 49.14%. The firm had revenue of $4.24 billion during the quarter, compared to the consensus estimate of $4.15 billion. During the same quarter last year, the firm earned $2.97 EPS. The firm’s revenue for the quarter was down 9.7% compared to the same quarter last year.

Several equities analysts have recently weighed in on MOH shares. Jefferies Financial Group downgraded Molina Healthcare from a “buy” rating to a “hold” rating and cut their target price for the company from $133.00 to $120.00 in a research report on Wednesday, October 30th. ValuEngine upgraded Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Friday, November 29th. Deutsche Bank initiated coverage on shares of Molina Healthcare in a research note on Thursday, September 12th. They set a “buy” rating and a $145.00 price objective for the company. Finally, Morgan Stanley cut their price objective on shares of Molina Healthcare from $184.00 to $172.00 and set an “overweight” rating on the stock in a research report on Friday, August 23rd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $155.89.

In related news, Director Ronna Romney sold 375 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $121.97, for a total value of $45,738.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Dale B. Wolf sold 3,500 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $135.51, for a total value of $474,285.00. Following the completion of the transaction, the director now directly owns 8,461 shares in the company, valued at approximately $1,146,550.11. The disclosure for this sale can be found here. Corporate insiders own 0.77% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in MOH. Nuveen Asset Management LLC purchased a new position in shares of Molina Healthcare in the 2nd quarter worth approximately $102,187,000. Boston Partners purchased a new stake in shares of Molina Healthcare during the 2nd quarter valued at $82,898,000. AQR Capital Management LLC lifted its holdings in shares of Molina Healthcare by 31.7% during the 2nd quarter. AQR Capital Management LLC now owns 954,433 shares of the company’s stock valued at $133,945,000 after purchasing an additional 229,987 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in Molina Healthcare by 294.0% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 198,457 shares of the company’s stock worth $21,776,000 after buying an additional 148,085 shares during the last quarter. Finally, Renaissance Technologies LLC increased its position in Molina Healthcare by 3.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,831,905 shares of the company’s stock valued at $548,499,000 after buying an additional 136,700 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Shares of NYSE:MOH traded up $0.81 during trading on Thursday, hitting $133.30. The company had a trading volume of 408,700 shares, compared to its average volume of 471,579. The stock has a market cap of $8.31 billion, a price-to-earnings ratio of 12.03, a price-to-earnings-growth ratio of 1.22 and a beta of 1.16. Molina Healthcare has a one year low of $105.28 and a one year high of $159.00. The company has a fifty day simple moving average of $127.53 and a two-hundred day simple moving average of $130.84. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.78 and a quick ratio of 1.78.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

See Also: What is quantitative easing?

Get a free copy of the Zacks research report on Molina Healthcare (MOH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.